WLLW — Willow Biosciences Share Price
0.000.00%
Last trade - 00:00- CA$11.43m
- CA$10.42m
- CA$1.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.33 | ||
| Price to Tang. Book | 3.33 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.75 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -271.18% | ||
| Return on Equity | -131.54% | ||
| Operating Margin | -1124.74% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0 | 0.01 | 0.13 | 0.82 | 1.17 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.
Directors
- Peter Seufer-Wasserthal NEC
- Trevor Peters PRE
- Travis Doupe CFO
- Chris Savile COO
- Peter Facchini CSO (58)
- Mathias Schuetz VPR
- Troy Talkkari VPR
- Sanjib Gill SEC
- Donald Archibald IND
- Al Foreman IND
- Fotiz Kalantzis IND
- Sadiq Lalani IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- September 14th, 2017
- No. of Employees
- 19
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 126,950,810
- Address
- 202, 1201 5th Street SW, CALGARY, T2R 0Y6
- Web
- https://www.willowbio.com/
- Phone
- +1 4039105140
- Auditors
- KPMG LLP
Upcoming Events for WLLW
Willow Biosciences Inc Annual Shareholders Meeting
Q2 2024 Willow Biosciences Inc Earnings Release
Similar to WLLW
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
Charlotte's Web Holdings
Toronto Stock Exchange
FAQ
What is the Willow Biosciences share price?
As of Today at 19:23 UTC, shares in Willow Biosciences are trading at CA$0.09. This share price information is delayed by 15 minutes.
How has the Willow Biosciences share price performed this year?
Shares in Willow Biosciences last closed at CA$0.09 and the price had moved by -30.77% over the past 365 days. In terms of relative price strength the Willow Biosciences share price has underperformed the Toronto Stock Exchange 300 Composite Index by -34.72% over the past year.
What are the analyst and broker recommendations for Willow Biosciences?
The overall consensus recommendation for Willow Biosciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Willow Biosciences dividend yield?
Willow Biosciences does not currently pay a dividend.
Does Willow Biosciences pay a dividend?
Willow Biosciences does not currently pay a dividend.
When does Willow Biosciences next pay dividends?
Willow Biosciences does not currently pay a dividend.
How do I buy Willow Biosciences shares?
To buy shares in Willow Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Willow Biosciences?
As of the previous close price of CA$0.09, shares in Willow Biosciences had a market capitalisation of CA$11.43m.
Where are Willow Biosciences shares listed?
Here are the trading details for Willow Biosciences:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: WLLW
What kind of share is Willow Biosciences?
Based on an overall assessment of its quality, value and momentum Willow Biosciences is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Willow Biosciences share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Willow Biosciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Willow Biosciences. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -3.07%.
As of the last closing price of CA$0.09, shares in Willow Biosciences were trading -8.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Willow Biosciences PE Ratio?
The Willow Biosciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Willow Biosciences?
Willow Biosciences' management team is headed by:
- Peter Seufer-Wasserthal - NEC
- Trevor Peters - PRE
- Travis Doupe - CFO
- Chris Savile - COO
- Peter Facchini - CSO
- Mathias Schuetz - VPR
- Troy Talkkari - VPR
- Sanjib Gill - SEC
- Donald Archibald - IND
- Al Foreman - IND
- Fotiz Kalantzis - IND
- Sadiq Lalani - IND